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Introduction
From the early stages of carcinogenesis, replication-associated 
lesions trigger DNA damage responses (Bartkova et al., 2005; 
Gorgoulis et al., 2005), which are mediated by the phosphatidy-
linositol-3-kinase–like protein kinases (PI3KKs) ataxia-telangiectasia 
mutated (ATM), ataxia-telangiectasia and RAD3-related (ATR), 
and DNA-dependent protein kinase (DNA-PK) catalytic subunit 
(DNA-PKcs). ATM signals DNA double-strand breaks (DSBs), 
whereas ATR responds to a variety of obstacles that block the 
progression of replication forks (Jackson and Bartek, 2009). 
Activated ATM and ATR phosphorylate hundreds of substrate 
proteins to activate DNA repair mechanisms and adjust ongoing 
physiological processes (Matsuoka et al., 2007). Two important 
targets of ATR and ATM are Chk1 and Chk2, which implement 
cell cycle checkpoints (Abraham, 2001).
ATR activation depends on the nucleation of multiple 
factors that bind single-stranded DNA (ssDNA) and 5 double-
stranded DNA to single-stranded DNA (ds/ssDNA) junctions 
(MacDougall et al., 2007; Van et al., 2010). The ATR sig-
nal is amplified when either ssDNA or ds/ssDNA junctions 
accumulate (Byun et al., 2005; MacDougall et al., 2007; Van 
et al., 2010). The recruitment of ATR to stalled replication forks 
is mediated by ATRIP, which binds human replication protein 
A (RPA) bound to ssDNA (Zou and Elledge, 2003). ATRIP also 
facilitates the recruitment of TopBP1 (Choi et al., 2010), a direct 
activator of the ATR–ATRIP complex (Kumagai et al., 2006).
DNA-PKcs is recruited to DNA ends by Ku70–Ku80 and 
activated upon binding to DNA (Dvir et al., 1992; Gottlieb and 
Jackson, 1993). DNA-PKcs is a central component of the machin-
ery that repairs DSBs by nonhomologous end joining (NHEJ; 
Smith and Jackson, 1999). DNA-PKcs has additional functions, 
notably in telomere maintenance and in the response to DNA 
replication stress (Smith and Jackson, 1999; Allen et al., 2011).
DNA-PKcs and ATR phosphorylate the 32-kD subunit of 
human RPA (RPA32) on multiple sites and these modifications 
promote DNA repair (Shao et al., 1999; Block et al., 2004; 
Sakasai et al., 2006; Anantha et al., 2007; Shi et al., 2010; Liaw 
et al., 2011). The underlying mechanism of functional cross talk 
between DNA-PKcs and ATR, however, remains elusive, and 
intriguing, as DNA-PKcs and ATR are recruited to and activated 
by distinct DNA structural elements, respectively, by DSBs and 
by RPA-covered ssDNA.
Three phosphatidylinositol-3-kinase–related protein kinases implement cellular responses to DNA damage. DNA-dependent protein kinase catalytic subunit 
(DNA-PKcs) and ataxia-telangiectasia mutated respond 
primarily to DNA double-strand breaks (DSBs). Ataxia-
telangiectasia and RAD3-related (ATR) signals the ac-
cumulation of replication protein A (RPA)–covered 
single-stranded DNA (ssDNA), which is caused by repli-
cation obstacles. Stalled replication intermediates can fur-
ther degenerate and yield replication-associated DSBs. 
In this paper, we show that the juxtaposition of a double-
stranded DNA end and a short ssDNA gap triggered ro-
bust activation of endogenous ATR and Chk1 in human 
cell-free extracts. This DNA damage signal depended on 
DNA-PKcs and ATR, which congregated onto gapped lin-
ear duplex DNA. DNA-PKcs primed ATR/Chk1 activation 
through DNA structure-specific phosphorylation of RPA32 
and TopBP1. The synergistic activation of DNA-PKcs and 
ATR suggests that the two kinases combine to mount a 
prompt and specific response to replication-born DSBs.
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in the presence of gDNA (Fig. 1 C). In contrast, markers of ATR 
activation were not visible when extracts were incubated with-
out DNA or in the presence of dsDNA (Fig. 1 C). To verify that 
DNA damage signals emanated from the defined gDNA mole-
cules, we labeled DNA substrates with biotin and then iso-
lated biotin DNA substrates from the reaction mixtures using 
streptavidin-coated beads. Ser345 pChk1 and Ser33 pRPA32 
were pulled down exclusively with gDNA (Fig. 1 D). RPA32 
also bound the DNA duplex (Fig. 1 D), most likely as a result of 
helix destabilization and binding to ssDNA (Lao et al., 1999). 
Ser33 pRPA32, however, was detected principally in associa-
tion with the gDNA substrate (Fig. 1 D).
Presumably, DNA damage signaling does not depend on 
DNA end resection because the DNA ends of duplex DNA and 
gDNA molecules would be equally susceptible to nucleases, 
and yet phosphorylation reactions were prompt and gDNA spe-
cific (Fig. 1). Consistent with this, we did not detect significant 
DNA degradation during a 1-h incubation in nuclear extracts 
(Fig. S2 A). In addition, linear DNA duplexes containing either 
a 68- or a 160-nt ssDNA gap equally induced Chk1 phosphory-
lation (Fig. S2 B), suggesting that nucleolytic enlargement of 
the ssDNA gap is not essential to trigger Chk1 activation. These 
data indicate that linear duplex DNA with a short ssDNA gap 
can promote the formation of a singularly active DNA damage 
signaling complex that phosphorylates endogenous protein sub-
strates in human cell-free extracts.
Juxtaposed DNA gap and DNA ends induce 
robust phosphorylation of RPA and Chk1
To dissect the structural determinants of DNA that activate 
DNA damage signaling, we supplemented the human nuclear 
extract with different forms of plasmid pG68 (Ralf et al., 2006). 
In addition to Ser33 pRPA32 and Ser345 pChk1, we probed 
the extracts for DNA-PKcs autophosphorylation on Ser2056, a 
marker of DNA-PKcs activation that occurs upon binding of 
DNA-PKcs to DNA ends. In an open circular form, the plasmid 
induced background phosphorylation of RPA32 on Ser33 and 
of DNA-PKcs on Ser2056, after 1 h of incubation in cell-free 
To gain insights into the mechanisms of replication check-
point signaling, we designed a DNA substrate that contains 
dsDNA ends and a short ssDNA gap. In human cell-free extracts, 
linear gapped DNA (gDNA) promotes the assembly of a potent 
ATR signaling complex that includes DNA-PKcs, ATR, RPA, 
and TopBP1. We propose a novel mechanism for the coopera-
tion of DNA-PKcs and ATR at collapsed replication forks.
Results and discussion
Induction of RPA and Chk1 phosphorylation 
in human cell-free extracts
During DNA replication, oncogenes and chemotherapeutic agents 
induce the accumulation of ssDNA gaps in newly replicated DNA 
and four-way junctions at replication forks (Fig. S1; Lopes et al., 
2006; Ray Chaudhuri et al., 2012; Neelsen et al., 2013). Whereas 
ssDNA gaps are fragile and prone to breaking (Lopes et al., 
2006), overwhelming DNA replication stress or checkpoint de-
fects can lead to the precocious processing of regressed forks by 
Mus81-Eme1 (Hanada et al., 2007; Neelsen et al., 2013; Szakal 
and Branzei, 2013). The collapse of these unusual replication 
intermediates is expected to yield DSBs that can activate DNA-
PKcs and ATM in DNA molecules containing ssDNA gaps that 
can trigger ATR activation (Fig. S1). To study how DNA mole-
cules that mimic broken replication intermediates are detected 
and signaled, we designed a linear duplex DNA molecule that 
contains one defined ssDNA gap (gDNA). The 573-bp DNA 
duplex was generated by PCR amplification of a DNA template 
(pG68) that comprises closely spaced recognition sites for a 
nicking endonuclease (Ralf et al., 2006). The nicks yield short 
oligonucleotides eliminated by heat denaturation. This treatment 
creates a 68-nt ssDNA gap in the DNA duplex and removes a 
SpeI restriction site (Fig. 1, A and B).
To monitor DNA damage signaling in vitro, we used human 
cell-free extracts and probed by Western blotting the phosphory-
lation of RPA32 at Ser33 (Olson et al., 2006) and of Chk1 at 
Ser345 (Guo et al., 2000; Liu et al., 2000). These phosphosig-
nals were induced in cell-free extracts after incubation for 15 min 
Figure 1. DNA damage signal activation in human cell-free extracts. 
(A) The duplex DNA substrates are blunt ended and 573 bp long. 
The gDNA contains a 68-nt single-stranded gap. (B) The gDNA is 
refractory to digestion with SpeI. (C) gDNA-specific phosphorylation 
of RPA32 and Chk1. Nuclear extracts were incubated without DNA 
(lane 1), with duplex DNA (lane 2), or with gDNA (lane 3). The 
indicated proteins were analyzed by Western blotting. (D) Proteins 
bound to biotinylated DNA were pulled down with streptavidin-
coated beads and detected by Western blotting. The dsDNA and 
gDNA substrates are represented schematically. Biotin (black circles) 
and streptavidin-coated beads (dented gray circles) are shown.
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efficient than in a reaction mixture supplemented with gapped 
linear duplex DNA (Fig. S2 C). In contrast, the induction of 
DNA-PKcs autophosphorylation was equivalent in both reactions 
(Fig. S2 C). Hence, the close juxtaposition of a dsDNA end and an 
ssDNA gap promotes DNA damage signaling. Although the dis-
tance between the DNA ends and the ssDNA gap was increased 
by more than fivefold in plasmid-based gDNA (Fig. 2 A) com-
pared with PCR-based gDNA (Fig. 1 A), both DNA substrates 
were potent inducers of DNA damage signaling. This indicates 
extracts (Fig. 2 A). As expected, linearized pG68 promptly trig-
gered DNA-PKcs autophosphorylation on Ser2056, whereas 
Chk1 and RPA32 remained unmodified (Fig. 2 A). The gapped 
circular plasmid DNA did not induce phosphosignals above 
background levels (Fig. 2 A). In contrast, Ser345 pChk1 and 
Ser33 pRPA32 were detected already after a 5-min incuba-
tion with gapped linear duplex DNA (Fig. 2 A). In a reaction 
mixture containing a combination of linear duplex DNA and 
gapped circular DNA molecules, Chk1 phosphorylation was less 
Figure 2. The juxtaposition of DNA ends and an ssDNA gap 
triggers activation of the DNA damage signal. (A) Nuclear 
extracts were incubated for the indicated time periods with 
open circular plasmid DNA (lanes 1–5), linear duplex DNA 
(lanes 6–10), gap circular DNA (lanes 11–15), or gapped lin-
ear duplex DNA (lanes 16–20). The indicated proteins were 
analyzed by Western blotting. (B) ATR activation depends on 
accessible DNA ends. (lanes 1–3) dsDNA and gDNA were 
biotinylated at both ends and incubated with nuclear extracts. 
(lanes 4–6) Biotinylated DNA substrates (5 nM) were prein-
cubated with 30 nM streptavidin for 15 min at 37°C before 
addition of nuclear extracts. (lanes 7–9) Unmodified DNA sub-
strates were preincubated with streptavidin before addition of 
nuclear extracts. The DNA substrates are represented sche-
matically. Biotin (black circles) and streptavidin (gray circles) 
are shown.
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at collapsed replication forks, we coupled the DNA fragments 
labeled with biotin at only one end with streptavidin-coated beads 
and then incubated the beads in nuclear extracts. The beads were 
isolated, and proteins associated with gDNA were analyzed by 
Western blotting. ATM, ATR, and DNA-PKcs were all pulled 
down with biotinylated DNA substrates (Fig. 3 A).
We then sought evidence of regulatory interplay between 
PIKKs using ATR-, ATM-, and DNA-PKcs–specific inhibitors. 
Two major clusters of phosphorylation sites in DNA-PKcs reg-
ulate the processing of DNA ends (Meek et al., 2008). DNA-PKcs 
autophosphorylation within the PQR cluster (Ser2056 cluster), 
protects DNA ends from nucleolytic resection while allowing 
access to components of the NHEJ machinery (Meek et al., 2008). 
In contrast, phosphorylation of DNA-PKcs within the ABCDE 
cluster (Thr2609 cluster) allows access to enzymes that trim 
DNA ends to promote homologous recombination (Meek et al., 
2008). This modification can be mediated by ATR in response 
to UV-induced DNA replication stress (Yajima et al., 2006). The 
ATM-specific inhibitor KU-55933 had no major impact on the 
phosphorylation of DNA-PKcs and ATR (Fig. 3 A). In contrast, 
that DNA damage signaling reactions are permissive to variations 
of the distance between the DNA ends and the ssDNA region.
To confirm that DNA ends were necessary to potentiate 
signals emanating from ssDNA, we labeled both 5 ends of the 
PCR-amplified gDNA product with biotin. 5-biotin labels did 
not impinge on gDNA-induced phosphorylation of DNA-PKcs 
and RPA32 (Fig. 2 B). When streptavidin was added to the re-
action mixture, however, phosphorylation reactions induced by 
biotin-labeled gDNA were inhibited (Fig. 2 B), most likely as a 
consequence of steric hindrance caused by streptavidin–biotin 
complexes at DNA ends. Consistent with this, streptavidin had 
no impact on phosphorylation reactions induced by gDNA in the 
absence of 5-biotin labels (Fig. 2 B). In conclusion, the juxta-
position of an ssDNA gap and DNA ends triggers the phos-
phorylation of RPA32 and Chk1 in human cell-free extracts.
Linear gDNA promotes the assembly of a 
potent ATR signaling complex
To characterize the composition of the DNA damage signaling 
complex and mimic single-ended DNA molecules that may arise 
Figure 3. Concerted activation of DNA damage signaling by DNA-PKcs, ATM, and ATR. (A) DNA-PKcs, ATM, and ATR bind to the biotinylated DNA 
substrates. DNA structures biotinylated at one DNA end were coupled to streptavidin-coated beads and then incubated with nuclear extracts for 10 min at 
20°C, in the absence or presence of the DNA-PKcs inhibitor IC86621 (100 µM), the ATM inhibitor KU-55933 (10 µM), or the ATR inhibitor ETP-46464 
(1 µM), as indicated. DNA-bound DNA-PKcs, ATM, and ATR were pulled down with streptavidin-coated beads, resolved by SDS-PAGE, and detected by 
Western blotting. (B) DNA-bound TopBP1 and Chk1 were isolated and detected as described in A. (C) Nuclear extracts prepared from cells treated with 
control shRNA or ATR shRNA were incubated with the indicated biotinylated DNA substrates, as described in A. ATR, DNA-PKcs, and Chk1 proteins were 
pulled down with streptavidin-coated beads, resolved by SDS-PAGE, and detected by Western blotting. (D) Nuclear extracts from cells treated with control 
shRNA or RPA shRNA were incubated for the indicated time periods with gDNA and probed for the indicated proteins by Western blotting. iDNA-PKcs, 
inhibitor of DNA-PKcs; iATM, inhibitor of ATM; iATR, inhibitor of ATR.
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beads were incubated with extracts from shRNA-treated cells, 
and then, protein–DNA complexes were purified and analyzed 
by Western blotting. Fig. 3 C shows that partial depletion of 
ATR was sufficient to completely abolish the phosphorylation 
of Chk1 on Ser345 and of DNA-PKcs on Thr2609.
Because the recruitment of ATR–ATRIP to ssDNA in vitro 
is stimulated by RPA (Zou and Elledge, 2003), we knocked down 
RPA to evaluate its role in gDNA-induced signaling (Fig. 3 D). 
The amount of total Chk1 protein was significantly reduced in 
extract prepared from RPA-depleted cells, most likely as a con-
sequence of Chk1 activation and degradation in response to stress 
induced by RPA depletion. Chk1, however, was more readily 
phosphorylated in RPA-depleted nuclear extracts than in con-
trol nuclear extracts (Fig. 3 D). Thus, RPA is not essential for 
Chk1 phosphorylation in this experimental setting.
In response to DNA replication stress, DNA-PKcs and ATR 
phosphorylate RPA32 on multiple sites, and these modifications 
promote DNA repair (Shao et al., 1999; Block et al., 2004; Sakasai 
et al., 2006; Anantha et al., 2007; Shi et al., 2010; Liaw et al., 
2011). To determine whether DNA-PKcs was necessary for 
gDNA-induced ATR signaling, we knocked down DNA-PKcs 
in HeLa cells and then prepared nuclear extracts from these 
cells. The knockdown of DNA-PKcs fully compromised the 
phosphorylation of RPA32 and Chk1 induced by linear gDNA 
(Fig. 4 A). Consistent with this, gDNA-induced Ser33 pRPA32 
and Ser345 pChk1 signals were detected in HCT116 cell-free 
extracts, absent in extracts prepared from isogenic HCT116 
homozygous knockout of DNA-PKcs, and detected again in 
the DNA-PKcs inhibitor IC86621 blocked the phosphorylation 
of DNA-PKcs on Ser2056 and partially interfered with DNA-
PKcs phosphorylation on Thr2609 (Fig. 3 A). Surprisingly, the 
ATR inhibitor ETP-46464 inhibited the phosphorylation of 
DNA-PKcs on Thr2609, specifically, along with phosphorylation 
of ATR on Thr1989 (Fig. 3 A). Thus, gDNA-induced signaling 
in cell-free extracts recapitulates a critical step in the regulation 
of DNA-PKcs by ATR. The phosphorylation of Xenopus laevis 
TopBP1 on Ser1131 augments the capacity of TopBP1 to acti-
vate the ATR–ATRIP complex (Yoo et al., 2009). TopBP1 was 
also retrieved with biotinylated DNA substrates (Fig. 3 B). 
TopBP1 associated indiscriminately with dsDNA and gDNA, 
but Ser1138 pTopBP1 was detected preferentially on the gDNA 
substrate (Fig. 3 B). Hence, gDNA-specific phosphorylation of 
TopBP1 may account for gDNA-induced ATR activation and 
Chk1 phosphorylation. Addition of any one of the three PIKKs 
inhibitors to the reaction mixtures interfered with gDNA-induced 
phosphorylation of TopBP1 on Ser1138 and of Chk1 on Ser345 
(Fig. 3 B). Compared with reaction mixtures containing DNA-
PKcs or ATR inhibitors, however, ATM inhibition had a lesser 
impact on RPA32 phosphorylation (Fig. 3 B). This suggests 
that ATR and DNA-PKcs can function synergistically to acti-
vate DNA damage signaling, in the presence of limited amount 
of ssDNA.
To verify the involvement of ATR in gDNA-induced phos-
phorylation events, we prepared nuclear extracts from HeLa cells 
treated either with a control shRNA or with an shRNA against 
ATR. Biotinylated DNA substrates coupled to streptavidin-coated 
Figure 4. DNA-PKcs is essential for DNA damage signal activation. (A) Nuclear extracts prepared from cells treated with control shRNA (shControl) or 
DNA-PKcs shRNA were incubated without DNA, with dsDNA, or with gDNA, and the indicated proteins were detected by Western blotting. (B) Nuclear 
extracts from HCT116 and HCT116 DNA-PKcs/ cells were incubated with gDNA, and HCT116 DNA-PKcs/ nuclear extracts were complemented with 
increasing amounts of DNA-PK purified from HeLa cells (0.025, 0.05, 0.1, 0.2, and 1 U/µl). (C) Nuclear extracts from cells treated with control shRNA or 
Ku70 shRNA were incubated for the indicated time periods with gDNA and probed for the indicated proteins by Western blotting. (D) Biotinylated DNA 
substrates were incubated with nuclear extracts in the absence or presence of IC86621 and pulled down, and the indicated DNA-bound proteins were 
analyzed by Western blotting. (E) Biotinylated DNA substrates were incubated with nuclear extracts from cells treated with control shRNA or ATR shRNA, 
isolated, and probed for the indicated proteins.
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phosphorylation and ATR activation but is dispensable for the 
congregation of DNA-PKcs, ATR, TopBP1, and Chk1 onto gDNA.
To verify the contribution of DNA-PKcs to ATR activa-
tion in a cellular context, we subjected U2OS cells to a high dose 
of camptothecin (CPT) that induces replication-born DSBs (Shao 
et al., 1999). We detected reduced levels of Ser345 pChk1 in cells 
treated with shRNAs against DNA-PKcs (Fig. S3 A) or Ku70 
(Fig. S3 B), as well as in cells treated with a small molecule in-
hibitor of DNA-PKcs (Fig. S3 C). These results indicate that 
DNA-PKcs contributes to sustain ATR signaling upon the col-
lapse of replication intermediates.
Here, we have shown that DNA-PKcs and ATR can com-
bine to form a potent DNA damage signaling complex that acti-
vates endogenous mediator and effector proteins in the ATR 
signal transduction pathway. A recent study has shown that the 
phosphorylation of RPA32 on Ser4 and Ser8 plays a significant 
role in ATR-mediated checkpoint activation and that the phos-
phorylation of RPA32 on multiple residues is amplified by a re-
ciprocal priming effect (Liu et al., 2012). PI3KKs target a subset 
of amino acids, and each phosphorylated amino acid primes the 
phosphorylation of a subset of N-terminal residues (Liu et al., 
2012). Consistent with this, our observation that inhibition of 
DNA-PKcs or ATR abolishes RPA32, TopBP1, and Chk1 phos-
phorylation is best explained by an amplification mechanism 
dependent on the synergistic action of DNA-PKcs and ATR. 
At replication-born DSBs, as in cell-free extracts, DNA-PKcs 
would amplify ATR signals in the presence of a limited amount 
of RPA-covered ssDNA, through priming of RPA32 and TopBP1 
phosphorylation. Previous studies have shown that RPA is nec-
essary to localize ATR–ATRIP at stalled forks but dispensable for 
Chk1 phosphorylation per se (Ball et al., 2005; Kim et al., 2005). 
extracts from HCT116 DNA-PKcs/ cells complemented with 
recombinant DNA-PK (Fig. 4 B). In addition, ablation of Ku70 by 
shRNA significantly interfered with gDNA-induced phosphory-
lation of Chk1 (Fig. 4 C). These data indicate that DNA-PK is 
necessary to prime ATR activation upon assembly onto gDNA.
To further investigate the intricate links between PI3KKs, 
we monitored the activation of ATM/Chk2 signaling. Chemical 
inhibition of DNA-PKcs interfered with ATM activation and 
Chk2 phosphorylation without preventing ATM and Chk2 
binding to DNA (Fig. 4 D). Consistent with this, we did not ob-
serve gDNA-induced Chk2 phosphorylation in nuclear extracts 
from DNA-PKcs–depleted cells (Fig. 4 E). These observations 
indicate that DNA-PKcs also connects with ATM signaling in-
duced by gDNA in cell-free extracts.
To verify that DNA-PKcs and ATR signaling proteins as-
sociate upon gDNA binding and activation, we immunoprecipi-
tated endogenous ATR from reaction mixtures supplemented 
with gDNA. The pull-down of DNA-PKcs, TopBP1, and Chk1 
with an anti-ATR antibody was strictly dependent on the pres-
ence of ATP (Fig. 5 A). DNA-PKcs, TopBP1, and Chk1 did not 
associate with ATR when ATP was omitted or replaced by the 
nonhydrolyzable analogue AMP-PNP (Fig. 5 A). This indicates 
that the assembly of the ATR signaling complex on gDNA is 
regulated by phosphorylation events. In contrast, we did not de-
tect ATM in the ATR immune precipitate (Fig. 5 B), suggesting 
that ATM is not tightly associated with this ATR signaling com-
plex. Ser1138 pTopBP1 and Ser345 pChk1 signals were notice-
able in the ATR immune precipitate (Fig. 5 C) but not detected in 
extracts containing the DNA-PKcs inhibitor IC86621 (Fig. 5 C), 
consistent with the data presented in Fig. 3 B. In conclusion, 
the enzymatic activity of DNA-PKcs is required for TopBP1 
Figure 5. ATP-dependent assembly of a DNA damage 
signaling complex. (A) Nuclear extracts were incubated 
for 10 min at 20°C with gDNA with or without 1 mM 
AMP-PNP or 1 mM ATP as indicated. Next, the reaction 
mixture was incubated overnight with an anti-ATR anti-
body, and ATR-associated proteins were pulled down 
with protein G–coupled magnetic beads, resolved by 
SDS-PAGE, and revealed by Western blotting with the 
indicated antibodies. (B) ATR immunoprecipitations were 
conducted as described in A and probed for ATM by 
Western blotting. (C) Reactions mixtures were assembled 
as described in A in the presence of 1 mM ATP, with 
or without 100 µM IC86621, as indicated. (D) Model 
for the concerted activation of DNA-PKcs and ATR. RPA 
binds to the ssDNA gap and promotes the recruitment of 
ATRIP–ATR. Ku binds the dsDNA end, may translocate 
up to dsDNA to ssDNA junction, and recruits DNA-PKcs. 
When amounts of RPA-covered ssDNA are limited, the 
concerted phosphorylation of RPA32 and TopBP1 by 
DNA-PKcs and ATR promotes signal amplification and 
assembly of a potent ATR signaling complex. IP, immuno-
precipitation; P, phosphorylated.
427Concerted activation of ATR and DNA-PKcs • Vidal-Eychenié et al.
Here, we observed that removal of RPA stimulated gDNA- 
induced Chk1 phosphorylation in cell-free extracts. These ob-
servations suggest that although RPA directs ATR–ATRIP to 
stalled forks, the ssDNA binding protein is not required for Chk1 
phosphorylation per se and that the hyperphosphorylation of 
RPA bound to ssDNA may overcome a barrier to Chk1 activation.
Our data are reminiscent of the findings by Kumagai and 
Dunphy (2000) who showed that the DNA substrate poly(dA)70-
poly(dT)70 can trigger the phosphorylation of xChk1 in X. laevis 
egg extracts. In this system, ATR activation occurs indepen-
dently of RPA, through phosphorylation of TopBP1 by ATM 
(Kim et al., 2005; Yoo et al., 2007). It would be interesting to 
define the key molecular features of poly(dA)70-poly(dT)70 that 
promote xChk1 phosphorylation and to examine whether xDNA-
PKcs is also necessary for xChk1 phosphorylation in X. laevis 
egg extracts.
Pioneering studies have demonstrated that the Ku70/80 
heterodimer first binds DNA ends independently of their exact 
structure (Paillard and Strauss, 1991; Falzon et al., 1993) and 
then translocates along duplex DNA to form a beads-on-a-string 
structure (de Vries et al., 1989; Paillard and Strauss, 1991; 
Zhang and Yaneva, 1992). Ku70/80 also exhibits specific affin-
ity for ssDNA to dsDNA transitions, including nicks and small 
ssDNA gaps (Blier et al., 1993; Falzon et al., 1993), and DNA-
PKcs interacts directly with RPA (Shao et al., 1999). The biochem-
ical properties of DNA-PK components suggest how DNA-PK 
may engage in ATR activation at replication-born DSBs. In the 
model presented in Fig. 5 C, we propose that Ku70/80 may first 
bind DNA ends, translocates up to internal nicks and ssDNA 
gaps, and then recruits DNA-PKcs, which phosphorylates RPA 
and primes ATR activation.
DNA-PKcs is extremely abundant. It represents 0.1–1% 
of soluble nuclear proteins in HeLa cells (Carter et al., 1990) 
and, therefore, is very likely to first bind replication-born DSBs. 
It is tempting to speculate that upon encountering DNA-bound 
RPA at broken replication intermediates, DNA-PKcs would be 
channeled to the ATR signaling pathway at the expense of 
NHEJ, thereby contributing to DNA repair pathway choice 
(Allen et al., 2011).
Materials and methods
Cells, proteins, and chemicals
U2OS and HeLa S3 cells were grown under standard conditions in DMEM 
(Invitrogen) supplemented with 10% FBS and 1% penicillin-streptomycin. 
HCT116 (cell line and genotype: HCT116 Hendrickson’s Parental; Horizon 
Discovery Ltd.) and HCT116 DNA-PKcs/ cells (clone: w87; cell line and 
genotype: HCT116 DNA-PKcs/; Horizon Discovery Ltd.) were cultured in 
McCoy’s 5A modified medium (Sigma-Aldrich) supplemented with 10% FBS 
and 1% penicillin-streptomycin. DNA-PK purified from HeLa cells was pur-
chased from Promega. Streptavidin and CPT were purchased from Sigma-
Aldrich. KU-55933 was obtained from Tocris Bioscience. IC86621 was obtained 
from Merck. ETP-46464 was a gift from O. Fernandez-Capetillo (Spanish 
National Cancer Research Centre, Madrid, Spain; Toledo et al., 2011).
Antibodies
Primary antibodies were purchased from Abcam (DNA-PKcs and DNA-
PKcs-S2056), Bethyl Laboratories, Inc. (ATM, ATR, TopBP1, RPA32-Ser33, 
and RPA32-Ser4/S8), EMD Millipore (RPA32 and Chk2), Cell Signaling 
Technology (Chk1-Ser345 and Chk2-Thr68), Rockland (ATM-Ser1981), 
Thermo Fisher Scientific (DNA-PKcs-Thr2609), and Santa Cruz Biotech-
nology, Inc. (Chk1). Antibodies against Ser1989 pATR (rabbit polyclonal 
antibody raised against the peptide NH2-Cys-FPENE(pT)PPEGK-COOH) 
and Ser1138 pTopBP1 (rabbit polyclonal antibody raised against the pep-
tide NH2-Cys-LNTEP(pS)QNEQI-COOH) were gifts from L. Zou (Massachu-
setts General Hospital and Harvard Medical School, Boston, MA) and 
W.G. Dunphy (California Institute of Technology, Pasadena, CA), respec-
tively. Secondary antibodies (anti–rabbit-HRP and anti–mouse-HRP) were 
obtained from Promega.
RNA interference
shRNA vectors were prepared by cloning dsDNA oligonucleotides into 
pSUPER-Puro (a gift from J. Lingner, Ecole Polytechnique Fédérale de 
Lausanne, Lausanne, Switzerland) as previously described (Azzalin and 
Lingner, 2006). The 19-nt target sequences were as follows: for DNA-PKcs, 
5-GATCGCACCTTACTCTGTT-3; for ATR, 5-GGAGATTTCCTGAGCA-
TGT-3; for RPA70, 5-CTGGTTGACGAAAGTGGTG-3; and for KU70, 
5-GGAAGAGATAGTTTGATTT-3. shRNA transfections were performed 
using Lipofectamine 2000 reagent (Invitrogen).
DNA substrates
Plasmid pG68 (Ralf et al., 2006) was generated by cloning an array of BbvCI 
restriction sites (insert A) into pUC18 using EcoRI and HindIII. Insert A is as follows: 
5-GAATTCGCCTCATCTCTGGCTTCCCGGATCCCAGGATGCGCAGGC-
AGCCGCCTAGGGTGACAGGCTCATGGATATGCTGAGGAATCGCTGA-
GGCGTAGCTGAGGACTAGTGCTGAGGGATCGCTGAGGTGTAGCTGA-
GGACGTGCTGAGGTGCGTCAGCTACTTGTGAACTCGAGAGGCTCAGTGA-
GTGAAGCTCCATGGCCTAAGGGCAGCAGACTAAGCTT-3. Plasmid 
pG160 (Gari et al., 2008) was generated by cloning an array of BbvCI and BsmI 
restriction sites (insert B) into pUC18 using EcoRI and HindIII. Insert B is as 
follows: 5-GAATTCGCTCCATCTCTGGCTTCCCGCTAGCCATTATGCGCA-
GGCAGCCGCCTAGGGTGACAGGCTCATGGATATGAATGCACTCGAG-
GAATGCACGGTAGAATGCAAAGAATGCAGGTTGAATGCATTAGAATGC-
CCCATGGGAATGCACAGAGAATGCAGTATCGAATGCAAATCGAATG-
CACGTACCTCAGCGATCCCTCAGCACTAGTCCTCAGCTGTACCTCAG-
CACGTCCTCAGCAAGCTT-3.
Biotinylated duplex DNA was generated by PCR amplification of 
plasmid pG68 or of plasmid pG160 using primer 1 (5-biotin-TGCGGCAT-
CAGAGCAGATTG-3) and primer 2 (5-GCACCCCAGGCTTTACACTTT-
ATG-3). To produce gDNA molecules, the duplex amplified from pG68 
(68-nt gap) was nicked with NbBbvC1 (New England Biolabs, Inc.), and 
the duplex amplified from pGAP160 (160-nt gap) was nicked with BsmI 
and NtBbvC1 (New England Biolabs, Inc.), resulting in the formation of 
short oligonucleotides (11–13 nt), which were melted by heat denaturation 
at 80°C and removed using a gel extraction spin column (QIAquick Gel 
Extraction Kit; QIAGEN) as previously described (Ralf et al., 2006). gDNA 
fragments were control digested with SpeI and purified by 0.8% agarose 
gel electrophoresis and electroelution using an Elutrap device (Schleicher 
& Schuell BioScience). Open circular pG68 was generated by treatment of 
supercoiled pG68 with topoisomerase I. pG68 was gapped with NbBbvC1 
as described in this paragraph. Plasmid pG68 was linearized with ScaI.
Nuclear extracts
Nuclear extracts were prepared using Dignam’s method as previously de-
scribed (Shiotani and Zou, 2009). HeLa S3 or HCT116 cells were grown 
to ≤80% confluence, collected by scrapping and centrifugation (200 g for 
3 min at 4°C), and washed twice in PBS. The cell pellet was suspended in 
5× packed cell volume of hypotonic buffer A (10 mM Hepes-KOH, pH 7.9, 
10 mM KCl, 1.5 mM MgCl2, 0.5 mM DTT, and 0.5 mM PMSF) supplemented 
with a cocktail of protease inhibitors (cOmplete, EDTA free; Roche) and 
phosphatase inhibitors (Thermo Fisher Scientific) and incubated on ice for 
5 min. Next, the cells were spun down at 500 g for 5 min, suspended in 
2× packed cell volume of buffer A and lysed by dounce homogeniza-
tion using a tight-fitting pestle. Nuclei were collected by centrifugation at 
4,000 g for 5 min at 4°C and extracted in one nuclei pellet volume of buf-
fer C (20 mM Hepes-KOH, pH 7.9, 600 mM KCl, 1.5 mM MgCl2, 0.2 mM 
EDTA, 25% glycerol, 0.5 mM DTT, and 0.5 mM PMSF) supplemented with 
cocktails of protease and phosphatase inhibitors, and mixed on a rotating 
wheel at 4°C for 30 min. Nuclear extracts (supernatants) were recovered 
by centrifugation (16,000 g for 15 min at 4°C) and dialyzed using Slide-
A-Lyzer Dialysis Cassettes (3,500-D protein molecular weight cutoff; Thermo 
Fisher Scientific) against buffer D (20 mM Hepes-KOH, pH 7.9, 100 mM 
KCl, 0.2 mM EDTA, 20% glycerol, 0.5 mM DTT, and 0.5 mM PMSF). Dia-
lyzed nuclear extracts were centrifuged (100,000 g for 30 min at 4°C) to 
eliminate residual precipitates. The protein concentration of the clear super-
natant was determined using Bradford’s estimation method, and aliquots 
were snap frozen and stored at 80°C.
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ATR activation assay
10 µl reaction mixtures contained 5 µg nuclear extracts, 5 nM of the indi-
cated DNA substrates, 10 mM Hepes-KOH, pH 7.6, 50 mM KCl, 0.1 mM 
MgCl2, 1 mM PMSF, 0.5 mM DTT, 1 mM ATP, 10 µg/ml creatine kinase, 
and 5 mM phosphocreatine. AMP-PNP, used at 1 mM when indicated, 
was obtained from Roche. Phosphorylation reactions were conducted at 
37°C for 15 min, unless otherwise indicated, and stopped with 10 µl of 2× 
protein sample buffer (125 mM Tris, pH 6.8, 2% SDS, 10% glycerol, 100 mM 
DTT, 2% -mercaptoethanol, and 0.004% bromophenol blue) for 3 min at 
37°C. For ATR pull-down experiments, reaction mixtures were supple-
mented with 1 µg anti-ATR antibody and incubated overnight on a rotated 
wheel at 4°C. Antibody–protein complexes were immunoprecipitated for 
1 h at 4°C with Dynabeads coupled to protein G (Invitrogen), washed, and 
resuspended in 2× protein sample buffer for Western blot analysis.
DNA pull-down assay
Biotinylated DNA duplexes (500 ng) were attached to 5 µl streptavidin-
coated magnetic beads (Bio-Adembeads; ADEMTECH) in binding and 
washing buffer (100 mM Tris, pH 7.5, and 1 M NaCl) and incubated for 
15 min at room temperature. Then, the beads were washed with 10 mM 
Hepes, pH 7.6, 100 mM KOAc, and 0.1 mM MgOAc and resuspended in 
reaction buffer (10 mM Hepes, pH 7.6, 50 mM KOAc, 0.1 mM MgOAC, 
1 mM PMSF, 0.5 mM DTT, 1 mM ATP, pH 7.0, 10 µg/ml creatine phos-
phate, 5 mM phosphocreatine, and 0.5 mg/ml BSA). 50 µl reaction mix-
tures containing 20 µg nuclear extracts and 500 ng DNA duplexes coupled 
to magnetic beads were incubated for 10 min at 37°C in reaction buffer.
Online supplemental material
Fig. S1 summarizes schematically how broken replication intermediates con-
taining DNA ends and ssDNA gaps are generated under stressful con-
ditions of DNA replication. Fig. S2 provides further information on the 
stability of DNA substrates in cell-free extracts and on key DNA structural 
determinants in ATR signaling. Fig. S3 shows that DNA-PKcs contributes 
to ATR signaling in U2OS cells exposed to the topoisomerase I poison 
CPT. Online supplemental material is available at http://www.jcb.org/ 
cgi/content/full/jcb.201304139/DC1.
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